Dr. Mikhail Blagosklonny is a brilliant professor of oncology who has dedicated his life to pursuing the cure for cancer. He has applied his expertise in basic science to come up with different ways to attack cancer by exploiting drug-resisting nature of cancer cells to do so.
Medical interests also expand to anti-aging drugs. His research on the science behind the process of cell cycle has led to knowledge in how to preserve perfectly healthy human cells and apply them to combat cancer and the aging process.
His two medical fields, aging, and cancer, have a lot in common characteristics hence they complement each other. He has used his knowledge from cancer research to advance his knowledge in the mechanism behind the aging process and vice versa.
Reputable researchers, himself included have proposed on multiple times the use of the drug rapamycin in the fight against cancer. Rapamycin is an anti-aging drug he helped create.
Impact Journals revealed that Mikhail Blagosklonny contributions in the oncology field, as well as the larger scientific research field, cannot be ignored. He has written countless oncology research papers as well as scientific articles to share his infinite knowledge on the subject.
His scientific publications are spread over a myriad of oncology and scientific journals including Oncotarget, a peer-reviewed medical journal covering oncology research and is published on a weekly basis by Impact Journals.
Dr. Mikhail Blagosklonny founded Oncotarget in 2010. Other publications consist of Aging Journals and Oncoscience. Some of his major achievements towards the discovery of a cure for cancer is his chemotherapeutic and cyclotherapy reverse engineering approaches in cancer treatment. He is an associate editor and chief co-editor for several reputable medical journals in the world of scientific medical research.
Education and Current Position
According to Research Gate, Mikhail Blagosklonny has an M.D in internal medicine which he earned from First Pavlov State Medical University, based in St. Petersburg’s where he also got his Ph.D. in cardiology and experimental medicine. He has worked as an associate professor at the New York Medical College in the early 2000s.
At the moment, Mikhail Blagosklonny is an oncology professor at the renowned Roswell Park Cancer Institute, NY. He spends most of his time in the lab trying to come up with ways to improve the lives of cancer patients and increasing its longevity at the same time. His latest project, Oncotarget has seen tremendous success of late and is on the verge of expanding to other medical disciplines.